Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail

Nonalcoholic fatty liver disease (NAFLD) is a global epidemic that is likely to become the most common cause of chronic liver disease in the next decade, worldwide. Though numerous drugs have been evaluated in clinical trials, most of them have returned inconclusive results and shown poorly-tolerate...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Mithun, Premkumar, Madhumita, Kulkarni, Anand V, Kumar, Pramod, Reddy, D Nageshwar, Rao, Nagaraja Padaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868704/
https://www.ncbi.nlm.nih.gov/pubmed/33604254
http://dx.doi.org/10.14218/JCTH.2020.00055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868704/
https://www.ncbi.nlm.nih.gov/pubmed/33604254
http://dx.doi.org/10.14218/JCTH.2020.00055

Ejemplares similares